Joel Greenblatt Biocryst Pharmaceuticals Inc Transaction History
Gotham Asset Management, LLC
- $11.5 Billion
- Q1 2025
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Gotham Asset Management, LLC holds 44,064 shares of BCRX stock, worth $483,822. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,064Holding current value
$483,822% of portfolio
0.0%Shares
14 transactions
Others Institutions Holding BCRX
# of Institutions
293Shares Held
177MCall Options Held
721KPut Options Held
489K-
Vanguard Group Inc Valley Forge, PA21.7MShares$238 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$219 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.93MShares$98 Million5.64% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.7MShares$95.5 Million1.06% of portfolio
-
State Street Corp Boston, MA7.81MShares$85.8 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $2.04B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...